化学性质：                                                                                                             

产品描述：                                                                                                            

Benzyl Quinolone Carboxylic Acid (BQCA) is a highly selective allosteric potentiator of the M1 muscarinic acetylcholine receptor (mAChR) [1].

M1 is most abundantly mAChR expressed in the hippocampus, cortex, and striatum, and localizes to postsynaptic membranes. M1 regulates several ion channels such as KCNQ inwardly rectifying K+currents, voltage-gated calcium channels, and NMDA receptors. M1 mediates the cognitive effects of ACh. M1 activation could slow AD progression by reducing Aβ42 peptides [1].

In vitro: BQCA alone showed no effect on calcium mobilization up to 10 μM but increased ACh potency 128.8 ± 20.1-fold at 100 μM. In CHO cells stably expressing human M1, BQCA (100 μM) activated M1 in the absence of ACh to an approximate 50% maximal response. BQCA had no effect on M2–M5, indicating 100-fold selectivity [1]. BQCA dose-dependently reduced the concentration of acetylcholine required to activate the M1 receptor [1]. The effective range for potentiation of M1 in cells by BQCA was 0.1 to 100 μM, with an inflection point value of 845 nM when 3 nM acetylcholine was used [1].

In vivo: In wild-type mice, BQCA (15 mg/kg) induced c-fos and arc RNA in the cortex, hippocampus, and cerebellum and the arc was also elevated in the striatum. BQCA had no effect in M1-/- mice. In wild-type mice, oral administration of 15 mg/kg BQCA increased the ratio of phosphoERK (pERK) to total ERK by 28%. BQCA showed excellent brain penetration and increased the firing rate of medial prefrontal cortex neurons in vivo in rats [2].

特别提醒：